stoxline Quote Chart Rank Option Currency Glossary
  
bioAffinity Technologies, Inc. (BIAF)
2.91  0.08 (2.83%)    04-17 16:00
Open: 2.89
High: 3.1
Volume: 209,537
  
Pre. Close: 2.83
Low: 2.8874
Market Cap: 34(M)
Technical analysis
2024-04-17 4:45:18 PM
Short term     
Mid term     
Targets 6-month :  3.62 1-year :  4.22
Resists First :  3.09 Second :  3.62
Pivot price 2.45
Supports First :  2.17 Second :  1.6
MAs MA(5) :  2.64 MA(20) :  2.35
MA(100) :  1.77 MA(250) :  1.71
MACD MACD :  0.2 Signal :  0.1
%K %D K(14,3) :  81.3 D(3) :  66.2
RSI RSI(14): 67.3
52-week High :  3.61 Low :  0.95
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BIAF ] has closed below upper band by 10.3%. Bollinger Bands are 94% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.1 - 3.11 3.11 - 3.12
Low: 2.86 - 2.87 2.87 - 2.88
Close: 2.89 - 2.91 2.91 - 2.92
Company Description

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Headline News

Tue, 16 Apr 2024
bioAffinity Technologies (BIAF) & The Competition Head-To-Head Analysis - Defense World

Sun, 14 Apr 2024
Contrasting bioAffinity Technologies (BIAF) and Its Competitors - Defense World

Mon, 01 Apr 2024
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire

Fri, 08 Mar 2024
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and ... - PR Newswire

Wed, 06 Mar 2024
Why BioAffinity Technologies (BIAF) Shares Are Down 50% - bioAffinity Technologies (NASDAQ:BIAF) - Benzinga

Wed, 06 Mar 2024
bioAffinity Technologies secures $2.5 million in stock sale By Investing.com - Investing.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 0 (M)
Shares Float 11 (M)
Held by Insiders 7.15e+006 (%)
Held by Institutions 34.7 (%)
Shares Short 25 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -7.6e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -105.9 %
Return on Assets (ttm) -48.9 %
Return on Equity (ttm) -99.9 %
Qtrly Rev. Growth 94 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 55130
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android